OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review.
Retro, which is backed by Sam Altman, has been working with OpenAI for roughly a year on this research, according to the report. The GPT-4b micro model tries to re-engineer proteins — a specific set called the Yamanaka factors — that can turn human skin cells into young-seeming stem cells. Retro believes these proteins are a promising step toward building human organs and providing supplies of replacement cells.
The model differs slightly from Google’s Nobel prize-winning AlphaFold, which predicts the shape of proteins, but it appears to be OpenAI’s first model that is custom-built for biological research. OpenAI and Retro tell the MIT Technology Review they plan to release research on the model and its outputs.
Krafton leads Cashfree’s $53M funding at $700M valuation
Cashfree, an Indian payments startup that facilitates and processes more than $80 billion for its customers each year, has raised...
Google wants Search to be more like an AI assistant in 2025
Google Search is in the midst of a “journey” around AI, Google CEO Sundar Pichai said during the company’s earnings...
Alphabet praises DeepSeek, but it’s massively ramping up its AI spending
Booming AI budgets seemed at risk last week when DeepSeek crashed Nvidia’s stock based on speculation that its cheaper AI models would lower demand...
Brightpick’s new warehouse robot can reach 20-foot-high shelves
Brightpick, a maker of autonomous mobile robots, on Tuesday announced a lofty addition to its current line. The appropriately named...
